Medelis is a full service oncology clinical research company, focused on oncology clinical trials design and management, including patient recruitment, for phase I and II studies in North America and Europe.
Our team has the experience, relationships and processes for rapid patient recruitment for those hard-to-reach patient populations in complex oncology clinical trials.
We specialize in oncology, and our entire team has deep oncology trial experience and expertise — from our world-class medical advisory board to our clinical team members and medical personnel.
This critical first-hand experience in the complex issues often associated with oncology clinical trials means that highly experienced resources will be working on your study.
Medelis has handled most targets within oncology. Whether it’s a standard dose-escalation phase I trial or a complex rescue of a phase III trial, chances are that our team has handled it before.
Our clinical team’s comprehension of the complex issues of oncology trials translates into better problem identification, decision making and superior results. We value innovation, and our experience allows us to work smarter, to maximize cost and time efficiencies on your trial.
We’re flexible, collaborative and proactive, and able to quickly adapt to study challenges or changes in the regulatory or competitive environment. This helps to speed a drug to market, and provides the decision support to determine your next clinical move.
We’d love to hear from you, and can provide feedback about your study design, investigators and patient recruitment, indications, and data collection.